Therapeutic opinion on endovascular repair for mycotic aortic aneurysm

Yao Kuang Huang, Po Jen Ko, Chyi Liang Chen, Feng Chun Tsai, Chi Hsiung Wu, Pyng Jing NLi, Cheng Hsun Chiu

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Our aim in this study was to assess the feasibility of endovascular repair for mycotic aortic aneurysms (MAAs) and to provide a therapeutic opinion. Methods: We retrospectively reviewed the records of 12 patients who underwent endovascular repair for MAAs between September 2006 and June 2011. Results: Patients consisted of 9 men and 3 women, with a median age of 64.6 years (range 45-75 years). The aortic aneurysms were in the thoracic/thoracoabdominal aorta in 5 patients, juxtarenal aorta with visceral involvement in 2 patients, and infrarenal abdominal aorta in 5 patients. Blood cultures of 10 patients (83.3%) were positive for bacteria and showed Salmonella species (8 patients), Klebsiella pneumonia (1 patient), and Escherichia coli (1 patients). Eight patients with active sepsis or active bleeding underwent emergent endovascular repair because of unstable hemodynamics. Notably, 2 patients required adjuvant surgery for complete removal of infectious foci. No deaths occurred within 30 days after intervention. We recorded 2 late deaths: 1 patient died of progressive pneumonia on day 39 after intervention and the other died of liver failure on day 58 after intervention. Late complications were observed in 3 patients, 1 of whom needed an aortic revision for late prosthesis infection. The mean follow-up time was 24 ± 19.7 months. Conclusions: Endovascular repair is a feasible therapeutic option for MAAs in that it can both stop bleeding and exclude the aneurysms. Although the aortic interventions performed were successful, the patients had an immunocompromised status and a difficult postoperative recovery. "Aggressive" surgical drainage may be necessary in some patients and may lead to a better outcome.

Original languageEnglish
Pages (from-to)579-589
Number of pages11
JournalAnnals of Vascular Surgery
Volume28
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Infected Aneurysm
Aortic Aneurysm
Therapeutics
Hemorrhage
Abdominal Aorta
Liver Failure
Klebsiella pneumoniae
Immunocompromised Host
Thoracic Aorta
Salmonella

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Huang, Y. K., Ko, P. J., Chen, C. L., Tsai, F. C., Wu, C. H., NLi, P. J., & Chiu, C. H. (2014). Therapeutic opinion on endovascular repair for mycotic aortic aneurysm. Annals of Vascular Surgery, 28(3), 579-589. https://doi.org/10.1016/j.avsg.2013.07.009

Therapeutic opinion on endovascular repair for mycotic aortic aneurysm. / Huang, Yao Kuang; Ko, Po Jen; Chen, Chyi Liang; Tsai, Feng Chun; Wu, Chi Hsiung; NLi, Pyng Jing; Chiu, Cheng Hsun.

In: Annals of Vascular Surgery, Vol. 28, No. 3, 2014, p. 579-589.

Research output: Contribution to journalArticle

Huang, YK, Ko, PJ, Chen, CL, Tsai, FC, Wu, CH, NLi, PJ & Chiu, CH 2014, 'Therapeutic opinion on endovascular repair for mycotic aortic aneurysm', Annals of Vascular Surgery, vol. 28, no. 3, pp. 579-589. https://doi.org/10.1016/j.avsg.2013.07.009
Huang, Yao Kuang ; Ko, Po Jen ; Chen, Chyi Liang ; Tsai, Feng Chun ; Wu, Chi Hsiung ; NLi, Pyng Jing ; Chiu, Cheng Hsun. / Therapeutic opinion on endovascular repair for mycotic aortic aneurysm. In: Annals of Vascular Surgery. 2014 ; Vol. 28, No. 3. pp. 579-589.
@article{505c6d3a167049ff956df7b69e2763c7,
title = "Therapeutic opinion on endovascular repair for mycotic aortic aneurysm",
abstract = "Background: Our aim in this study was to assess the feasibility of endovascular repair for mycotic aortic aneurysms (MAAs) and to provide a therapeutic opinion. Methods: We retrospectively reviewed the records of 12 patients who underwent endovascular repair for MAAs between September 2006 and June 2011. Results: Patients consisted of 9 men and 3 women, with a median age of 64.6 years (range 45-75 years). The aortic aneurysms were in the thoracic/thoracoabdominal aorta in 5 patients, juxtarenal aorta with visceral involvement in 2 patients, and infrarenal abdominal aorta in 5 patients. Blood cultures of 10 patients (83.3{\%}) were positive for bacteria and showed Salmonella species (8 patients), Klebsiella pneumonia (1 patient), and Escherichia coli (1 patients). Eight patients with active sepsis or active bleeding underwent emergent endovascular repair because of unstable hemodynamics. Notably, 2 patients required adjuvant surgery for complete removal of infectious foci. No deaths occurred within 30 days after intervention. We recorded 2 late deaths: 1 patient died of progressive pneumonia on day 39 after intervention and the other died of liver failure on day 58 after intervention. Late complications were observed in 3 patients, 1 of whom needed an aortic revision for late prosthesis infection. The mean follow-up time was 24 ± 19.7 months. Conclusions: Endovascular repair is a feasible therapeutic option for MAAs in that it can both stop bleeding and exclude the aneurysms. Although the aortic interventions performed were successful, the patients had an immunocompromised status and a difficult postoperative recovery. {"}Aggressive{"} surgical drainage may be necessary in some patients and may lead to a better outcome.",
author = "Huang, {Yao Kuang} and Ko, {Po Jen} and Chen, {Chyi Liang} and Tsai, {Feng Chun} and Wu, {Chi Hsiung} and NLi, {Pyng Jing} and Chiu, {Cheng Hsun}",
year = "2014",
doi = "10.1016/j.avsg.2013.07.009",
language = "English",
volume = "28",
pages = "579--589",
journal = "Annals of Vascular Surgery",
issn = "0890-5096",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Therapeutic opinion on endovascular repair for mycotic aortic aneurysm

AU - Huang, Yao Kuang

AU - Ko, Po Jen

AU - Chen, Chyi Liang

AU - Tsai, Feng Chun

AU - Wu, Chi Hsiung

AU - NLi, Pyng Jing

AU - Chiu, Cheng Hsun

PY - 2014

Y1 - 2014

N2 - Background: Our aim in this study was to assess the feasibility of endovascular repair for mycotic aortic aneurysms (MAAs) and to provide a therapeutic opinion. Methods: We retrospectively reviewed the records of 12 patients who underwent endovascular repair for MAAs between September 2006 and June 2011. Results: Patients consisted of 9 men and 3 women, with a median age of 64.6 years (range 45-75 years). The aortic aneurysms were in the thoracic/thoracoabdominal aorta in 5 patients, juxtarenal aorta with visceral involvement in 2 patients, and infrarenal abdominal aorta in 5 patients. Blood cultures of 10 patients (83.3%) were positive for bacteria and showed Salmonella species (8 patients), Klebsiella pneumonia (1 patient), and Escherichia coli (1 patients). Eight patients with active sepsis or active bleeding underwent emergent endovascular repair because of unstable hemodynamics. Notably, 2 patients required adjuvant surgery for complete removal of infectious foci. No deaths occurred within 30 days after intervention. We recorded 2 late deaths: 1 patient died of progressive pneumonia on day 39 after intervention and the other died of liver failure on day 58 after intervention. Late complications were observed in 3 patients, 1 of whom needed an aortic revision for late prosthesis infection. The mean follow-up time was 24 ± 19.7 months. Conclusions: Endovascular repair is a feasible therapeutic option for MAAs in that it can both stop bleeding and exclude the aneurysms. Although the aortic interventions performed were successful, the patients had an immunocompromised status and a difficult postoperative recovery. "Aggressive" surgical drainage may be necessary in some patients and may lead to a better outcome.

AB - Background: Our aim in this study was to assess the feasibility of endovascular repair for mycotic aortic aneurysms (MAAs) and to provide a therapeutic opinion. Methods: We retrospectively reviewed the records of 12 patients who underwent endovascular repair for MAAs between September 2006 and June 2011. Results: Patients consisted of 9 men and 3 women, with a median age of 64.6 years (range 45-75 years). The aortic aneurysms were in the thoracic/thoracoabdominal aorta in 5 patients, juxtarenal aorta with visceral involvement in 2 patients, and infrarenal abdominal aorta in 5 patients. Blood cultures of 10 patients (83.3%) were positive for bacteria and showed Salmonella species (8 patients), Klebsiella pneumonia (1 patient), and Escherichia coli (1 patients). Eight patients with active sepsis or active bleeding underwent emergent endovascular repair because of unstable hemodynamics. Notably, 2 patients required adjuvant surgery for complete removal of infectious foci. No deaths occurred within 30 days after intervention. We recorded 2 late deaths: 1 patient died of progressive pneumonia on day 39 after intervention and the other died of liver failure on day 58 after intervention. Late complications were observed in 3 patients, 1 of whom needed an aortic revision for late prosthesis infection. The mean follow-up time was 24 ± 19.7 months. Conclusions: Endovascular repair is a feasible therapeutic option for MAAs in that it can both stop bleeding and exclude the aneurysms. Although the aortic interventions performed were successful, the patients had an immunocompromised status and a difficult postoperative recovery. "Aggressive" surgical drainage may be necessary in some patients and may lead to a better outcome.

UR - http://www.scopus.com/inward/record.url?scp=84897069538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897069538&partnerID=8YFLogxK

U2 - 10.1016/j.avsg.2013.07.009

DO - 10.1016/j.avsg.2013.07.009

M3 - Article

VL - 28

SP - 579

EP - 589

JO - Annals of Vascular Surgery

JF - Annals of Vascular Surgery

SN - 0890-5096

IS - 3

ER -